Drug traceability related policies are initiated in many provinces affecting all pharmacies

, Fujian Provincial Drug Administration held a video conference on the construction of the province's drug information traceability system, on the drug production and operation of enterprises to trace the progress of the work, the relevant deployment.In addition, on September 21, Hebei Provincial Drug Administration issued a notice, has officially launched the province's Chinese medicine tablets traceability work, 20 production enterprises and 77 franchise enterprises have been included in the retrospective scope for the first time.It can be said that in order to implement the Drug Administration Law and the State Drug Administration on drug information tracing system construction related work deployment, many provinces have entered the "accelerated period" to promote drug traceability work.

"reflow medicine" will become aOn November 1, 2018, the State Drug Administration officially issued the Guidance on the Construction of the Drug Information Tracing System (hereinafter referred to as the Opinion).The Opinions clearly state that drug listing license holders and production enterprises shall bear the primary responsibility for the construction of the drug traceability system, and pharmaceutical operating enterprises and user units shall, in cooperation with drug listing license holders and production enterprises, establish a complete drug traceability system and fulfill their respective retrospective responsibilities.In other words, the ecology of keeping only data from drug production to drug wholesale will be changed in the past, and in the future, drugs can be traced directly to medical institutions and retail pharmacy terminals.Combined with the Hebei Provincial Drug Administration issued "on the Chinese medicine drink tablets into the scope of drug circulation retrospective notice", Hebei Province, Chinese medicine drink tablets production pilot enterprises, Chinese medicine drink tablets franchise enterprises and the drug wholesale and retail enterprises have been connected to the network in accordance with data standardization control, data transmission interface docking and adjustment, data upload three steps to implement the Chinese medicine tablets traceability data reporting work.After the completion of the relevant data upload work, from November 1, 2020, Hebei Province pharmaceutical enterprises will formally report the Trace Data of Chinese medicine tablets.It is reported that as of August 2020, Hebei Province has 518 pharmaceutical wholesale enterprises, 386 retail chain headquarters (including 11,211 stores), 3,695 single pharmacies, to join the traceability system and report traceability data 350 million, initially formed a source to be traceable, to recover, responsibility can be traceability system.It can be said that after the establishment of the future traceability system, through health insurance, new agricultural co-operation and other means from hospitals or pharmacies to buy drugs, after illegal recyclers re-sell to pharmacies, clinics, and then sold to customers drugs, to take out the health insurance fund sales of reflow drugs phenomenon will be nowhere to hide.At the same time, in the daily flight inspection work, in view of the phenomenon of sales of reflow drugs, the regulatory authorities have carried out a number of inspection batches, check single number, examination of various types of drug purchase bills and other regulatory means will be more efficient.

drugstores, compliance survivesIn the long run, the establishment of drug traceability will undoubtedly put forward higher requirements for the compliance of pharmacy operations. So, when it comes to the various subjects of drug production and circulation, how will this policy affect the pharmaceutical industry as a whole?In this regard, Seber blue - pharmacy manager interview to the platform writer Code Wanxuan said that the drug traceability of pharmacies, and even the impact of pharmaceutical business, can be divided into several aspects:First, pharmacies become part of the information tracing system, will inevitably be the pharmacy information construction, behavior norms mandatory requirementsThe long-term impact is related to drug control and marketing, prescription outflow, and even pharmaceutical e-commerce and other aspects.   First, if pharmaceutical businesses and pharmacies participate in drug control and marketing, it may be difficult to avoid leaving traces in the time and space memory of the information-based traceability system Third, pharmaceutical manufacturers may ask for drug terminal sales records from the drug information traceability system, which will weaken the negotiating position of pharmaceutical businesses, pharmacies and pharmaceutical production enterprises   It can be said that once the drug traceability is carried out, pharmacies may have to face the above situation, and as the main body of operation, pharmacies in the drug traceability construction work responsibility is also very clear.

drug traceability, pharmacy responsibilities are clear   In the specific drug circulation process, the responsibilities of pharmacies as a point of sale are as follows: Pharmaceutical wholesale enterprises in the procurement of drugs, the upstream enterprises need to obtain relevant retrospective information, in the drug acceptance check, and check the information back to upstream enterprises;   When purchasing drugs, the retail and user units of drugs shall obtain relevant retrospective information from upstream enterprises, check them at the time of drug acceptance, and return the check information to upstream enterprises; (Pharmacy Manager)